Taija. Mäkinen, et.al., PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature., Genes & development, 2005, 19

http://rdf.ncbi.nlm.nih.gov/pubmed/15687262

Taija. Mäkinen, et.al., PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature., Genes & development, 2005, 19

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Efnb2<tm5.1Kln>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3573787
• Efnb2<tm6Kln>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3573786
• Efnb2<tm5Kln>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3573785

class

http://purl.org/net/cito/citesAsAuthority

• Efnb2<tm5.1Kln>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3573787
• Efnb2<tm6Kln>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3573786
• Efnb2<tm5Kln>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3573785

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• chylothorax_Efnb2<tm5.1Kln>/Efnb2<tm5.1Kln>
  http://metadb.riken.jp/0003660IC57BL6Efnb2tm51KlnEfnb2tm51KlnEfnb2tm51Kln
• premature death_Efnb2<tm5.1Kln>/Efnb2<tm5.1Kln>
  http://metadb.riken.jp/0002083ICD1Efnb2tm51KlnEfnb2tm51KlnEfnb2tm51Kln
• abnormal lymphatic vessel morphology_Efnb2<tm6Kln>/Efnb2<tm6Kln>
  http://metadb.riken.jp/0001879IC57BL6Efnb2tm6KlnEfnb2tm6KlnEfnb2tm6Kln
• chylothorax_Efnb2<tm5Kln>/Efnb2<tm5Kln>
  http://metadb.riken.jp/0003660IC57BL6Efnb2tm5KlnEfnb2tm5KlnEfnb2tm5Kln
• abnormal afferent lymphatic vessel morphology_Efnb2<tm5.1Kln>/Efnb2<tm5.1Kln>
  http://metadb.riken.jp/0002349IC57BL6Efnb2tm51KlnEfnb2tm51KlnEfnb2tm51Kln
• abnormal lymph circulation_Efnb2<tm6Kln>/Efnb2<tm6Kln>
  http://metadb.riken.jp/0003659IC57BL6Efnb2tm6KlnEfnb2tm6KlnEfnb2tm6Kln
• abnormal afferent lymphatic vessel morphology_Efnb2<tm5.1Kln>/Efnb2<tm5.1Kln>,Flt4<tm1Ali>/Flt4<+>
  http://metadb.riken.jp/0002349IC57BL6Efnb2tm51KlnEfnb2tm51KlnFlt4tm1AliFlt4Flt4tm1AliFlt4Efnb2tm51Kln
• postnatal lethality, complete penetrance_Efnb2<tm5Kln>/Efnb2<tm5Kln>
  http://metadb.riken.jp/0011085IC57BL6Efnb2tm5KlnEfnb2tm5KlnEfnb2tm5Kln
• chylothorax_Efnb2<tm5.1Kln>/Efnb2<tm5.1Kln>
  http://metadb.riken.jp/0003660ICD1Efnb2tm51KlnEfnb2tm51KlnEfnb2tm51Kln
• abnormal lymphatic vessel morphology_Efnb2<tm5.1Kln>/Efnb2<tm5.1Kln>,Flt4<tm1Ali>/Flt4<+>
  http://metadb.riken.jp/0001879IC57BL6Efnb2tm51KlnEfnb2tm51KlnFlt4tm1AliFlt4Flt4tm1AliFlt4Efnb2tm51Kln
• abnormal lymph circulation_Efnb2<tm5.1Kln>/Efnb2<tm5.1Kln>
  http://metadb.riken.jp/0003659IC57BL6Efnb2tm51KlnEfnb2tm51KlnEfnb2tm51Kln
• abnormal lymphatic vessel morphology_Efnb2<tm5.1Kln>/Efnb2<tm5.1Kln>
  http://metadb.riken.jp/0001879ICD1Efnb2tm51KlnEfnb2tm51KlnEfnb2tm51Kln
• abnormal lymphatic vessel morphology_Efnb2<tm5.1Kln>/Efnb2<tm5.1Kln>
  http://metadb.riken.jp/0001879IC57BL6Efnb2tm51KlnEfnb2tm51KlnEfnb2tm51Kln
• postnatal lethality, complete penetrance_Efnb2<tm5.1Kln>/Efnb2<tm5.1Kln>
  http://metadb.riken.jp/0011085IC57BL6Efnb2tm51KlnEfnb2tm51KlnEfnb2tm51Kln